Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries UPDATE 2-Catalent seeks slice of gene therapy market with Paragon buy By: Reuters: Company News April 15, 2019 at 10:59 AM EDT Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its biotech clients. Read More >> Related Stocks: Catalent Inc Sarepta Therapeutics Thermo Fisher Scientific Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
UPDATE 2-Catalent seeks slice of gene therapy market with Paragon buy By: Reuters: Company News April 15, 2019 at 10:59 AM EDT Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its biotech clients. Read More >> Related Stocks: Catalent Inc Sarepta Therapeutics Thermo Fisher Scientific